Primary Results of ROSE/TRIO-12, a Randomized...

Journal of Clinical Oncology 2015 / 01 Vol. 33; Iss. 2

Primary Results of ROSE/TRIO-12, a Randomized Placebo-Controlled Phase III Trial Evaluating the Addition of Ramucirumab to First-Line Docetaxel Chemotherapy in Metastatic Breast Cancer

Mackey, J. R., Ramos-Vazquez, M., Lipatov, O., McCarthy, N., Krasnozhon, D., Semiglazov, V., Manikhas, A., Gelmon, K. A., Konecny, G. E., Webster, M., Hegg, R., Verma, S., Gorbunova, V., Abi Gerges, D
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
33
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/jco.2014.57.1513
Date:
January, 2015
File:
PDF, 269 KB
english, 2015
Conversion to is in progress
Conversion to is failed